Frequently Asked Questions about Transition Fills

You can get a 30-day temporary or transition prescription drug fill if you: stayed with the same Medicare Part D prescription drug plan (or Medicare Advantage plan that includes drug coverage) . . .

Yes.  Medicare anticipates that Medicare Part D and Medicare Advantage plans will allow new plan members to file requests for formulary exceptions or coverage determinations before the beginnin . . .

A transition fill is a temporary 30-day prescription supply or refill of a non-formulary drug provided to: People who have stayed with the same Medicare drug plan into the next year and now fi . . .

Yes - but only in specific circumstances. Your Medicare Part D plan may provide you with a transition fill extension. However, such an extension is provided only on a case-by-case basis in exception . . .

Usually 90 days. Your 30-day supply transition fill is usually only valid for the first 90 days of your Medicare drug plan enrollment.If you are living in a long-term care (LTC) facility, then you . . .

As noted by the Centers for Medicare and Medicaid Services (CMS), for the purposes of the transition fill policy, non-formulary Medicare Part D drugs are: (1) Part D drugs that are not on a [Medic . . .

Yes.  If you reside in a long-term care (LTC) facility, and find that one of your of prescription medications is no longer covered by your current Medicare Part D plan (or Medicare Advantage pla . . .

If you are granted a 30-day transition fill, your Medicare Part D plan will charge you the same cost-sharing amount as you would pay if a formulary exception request has been granted and your non-fo . . .

A transition fill or 30-day temporary non-formulary drug supply is available to:People who did not change their Medicare plan coverage from the previous year and now find that their medications are . . .

Yes.  According to the Centers for Medicare and Medicaid Services (CMS), the transition fill policy will apply to both non-formulary Part D drugs and “Part D drugs that are on a sponsor&# . . .

As noted by the Centers for Medicare and Medicaid Services (CMS), for the purposes of the transition fill policy, non-formulary Medicare Part D drugs are: (1) Part D drugs that are not on a [Medic . . .

Your Medicare Part D plan's Evidence of Coverage document will provide you with information about what you will pay for a transition fill of a non-fomrulary drug.  You Evidence of Coverage is a . . .

No - unless the non-Part D drug is used for a medically-accepted indication.Specific prescription medications are excluded from the Medicare Part D program or sometimes medications are removed from th . . .

Yes.  Medicare anticipates that Medicare Part D and Medicare Advantage plans will allow new plan members to file requests for formulary exceptions or coverage determinations before the beginnin . . .

Yes - but only in specific circumstances. Your Medicare Part D plan may provide you with a transition fill extension. However, such an extension is provided only on a case-by-case basis in exception . . .

If you are granted a 30-day transition fill, your Medicare Part D plan will charge you the same cost-sharing amount as you would pay if a formulary exception request has been granted and your non-fo . . .

Yes.  If you reside in a long-term care (LTC) facility, and find that one of your of prescription medications is no longer covered by your current Medicare Part D plan (or Medicare Advantage pla . . .

A transition fill is a temporary 30-day prescription supply or refill of a non-formulary drug provided to: People who have stayed with the same Medicare drug plan into the next year and now fi . . .

A transition fill or 30-day temporary non-formulary drug supply is available to:People who did not change their Medicare plan coverage from the previous year and now find that their medications are . . .

Yes.  According to the Centers for Medicare and Medicaid Services (CMS), the transition fill policy will apply to both non-formulary Part D drugs and “Part D drugs that are on a sponsor&# . . .